Related Experiment Video
Updated: May 24, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Conference scene: immune effector mechanisms in tumor immunity
Andrew G Sikora1, Yared Hailemichael, Willem W Overwijk
1Departments of Otolaryngology, Immunology, Oncological Sciences & Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Abstract:
The 19th Annual Cancer Research Institute Cancer Immunotherapy Symposium was organized by the Cancer Research Institute in order to bring together researchers in basic, translational and clinical research, and industry representatives in order to exchange data, tools and opinions to further cancer immunotherapy. Our increasing understanding of immune mechanisms that mediate either the regression or progression of cancer is being translated into therapies that have begun to show true clinical benefit for cancer patients. The conference built on these early successes and aimed to push further into the uncharted territories of successful cancer immunotherapy.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cell-mediated Immune Responses
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
The Tumor Microenvironment
The Tumor Microenvironment
